Evidence map›Paper›PMID 27040952›Full record

ArticleJournal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry2016

Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo.

David Stíbal, Bruno Therrien, Georg Süss-Fink, Patrycja Nowak-Sliwinska, Paul J Dyson, Eva Čermáková, Martina Řezáčová, Pavel Tomšík

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

David StíbalInstitut de Chimie, Université de Neuchâtel, Neuchâtel, Switzerland.
Bruno TherrienInstitut de Chimie, Université de Neuchâtel, Neuchâtel, Switzerland. bruno.therrien@unine.ch.
Georg Süss-FinkInstitut de Chimie, Université de Neuchâtel, Neuchâtel, Switzerland.
Patrycja Nowak-SliwinskaInstitut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Paul J DysonInstitut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Eva ČermákováFaculty of Medicine in Hradec Králové, Computer Technology Center, Charles University in Prague, Hradec Králové, Czech Republic.
Martina ŘezáčováFaculty of Medicine in Hradec Králové, Department of Medical Biochemistry, Charles University in Prague, Hradec Králové, Czech Republic.
Pavel TomšíkFaculty of Medicine in Hradec Králové, Department of Medical Biochemistry, Charles University in Prague, Hradec Králové, Czech Republic. TomsikP@lfhk.cuni.cz.
Charles University · CZUniversity of Neuchâtel · CHÉcole Polytechnique Fédérale de Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Four diruthenium trithiolato chlorambucil conjugates have been prepared via Steglich esterification from chlorambucil and the corresponding trithiolato precursors. All conjugates are highly cytotoxic towards human ovarian A2780 and A2780cisR cancer cell lines with IC50 values in the nanomolar range. The conjugates exhibit selectivity towards A2780 cells as compared to non-cancerous HEK293 cells, while being only slightly selective for RF24 and A2780cisR cells. In vivo, the conjugate [10]BF4 suppressed the growth of a solid Ehrlich tumor in immunocompetent NMRI mice but did not prolong their overall survival. The reactivity of the chlorambucil conjugates with glutathione, a potential target of the dinuclear ruthenium motive, and with the 2-deoxyguanosine 5'-monophosphate (dGMP-a model target of chlorambucil) was studied by mass spectrometry and NMR spectroscopy. The conjugates did not show catalytic activity for the oxidation of glutathione nor binding to nucleotides, indicating that glutathione oxidation and DNA alkylation are not key mechanisms of action. Four highly cytotoxic diruthenium trithiolato chlorambucil conjugates have been prepared. All conjugates exhibit selectivity towards A2780 cells as compared to HEK293 cells, while being only slightly active in RF24 and A2780cisR cells. In vivo, the best candidate suppressed the growth of a solid Ehrlich tumor in immunocompetent NMRI mice but did not prolong their overall survival.

Indexed as

AnimalsAntineoplastic AgentsCell Line, TumorCell ProliferationChlorambucilCymenesDose-Response Relationship, DrugDrug Screening Assays, AntitumorFemaleHumansMiceMolecular ConformationMonoterpenesNeoplasms, ExperimentalOrganometallic CompoundsRuthenium4-cymeneAntineoplastic AgentsChlorambucilCymenesMonoterpenesOrganometallic CompoundsRutheniumSulfhydryl CompoundsAnticancer activityArene rutheniumChlorambucilDinuclear complexesIn vivo study

Identifiers

PMID27040952
OpenAlexW2336742406

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.